Guest guest Posted August 14, 2010 Report Share Posted August 14, 2010 Hello , Help me out here... I am a little confused. The reference you listed has this conclusion: " Immunization with mature dendritic cells loaded with a generic oxidized tumor cell line stimulates a polyclonal antitumor response that recognizes autologous tumor. " So, are you suggesting that MMS2 is the same as an immunization of oxidized tumor cells...? Where do you suggest we pick up the tumor cells to start with? We then would have to figure out the proper concentration of hypochlorous acid to oxidize them, and then we would have to figure out how, and where, to inject them. The down side is that if the ratio is off, the treatment may end up causing an autoimmune disease. Has Jim Humble done similar testing to make you feel comfortable that taking MMS2 doesn't trigger an autoimmune disease or cause other complications? Tom --- In , Stauffer <gsgkill@...> wrote: > > > http://clincancerres.aacrjournals.org/content/14/15/4898.full > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.